Nicomide

Nicomide is an acne medication available in topical cream, topical gel and vitamin supplement form (U.S. Patent No. 6,979,468). Tablets available by prescription only and contain the active ingredients nicotinamide, zinc, copper, and folic acid. The topical cream and topical gel are formulated into a 4% nicotinamide mixture. Dermatologists say this medication reduces inflammation of the skin, thereby reducing acne. Results from a well-controlled clinical trial in Caucasian and Japanese women have shown that 4-6 weeks of application of 2 percent nicotinamide moisturiser to the face decreases sebum production with significant differences in facial shine and oiliness.Nicotinamide gel is marketed as an over-the-counter treatment for acne in Canada, Australia, NZ, UK, USA and Ireland. If a twice-daily application causes excessive drying of the skin, one may reduce to once a day, or every other day.Nicotinamide gel is sold in Canada, Australia, NZ, UK, the USA and Ireland as an over-the-counter acne remedy. If a twice-daily application causes the skin to dry excessively, one may use once a day or every other day.Nicotinamide is highly not recommended for acne in pregnancy or nursing women.

Nicomide is distributed by Sirius Laboratories Inc., and now a wholly owned subsidiary of DUSA Pharmaceuticals, Inc. DUSA Pharmaceuticals ceased distributing Nicomide in June 2008 and set up an agreement with River's Edge Pharmaceuticals to allow them to distribute the product under DSHEA in August 2008 but the deal appears to have fallen through. The last time Nicomide was mentioned in DUSA's annual reports is March 2010.

External links

• Nicomide